AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (May 16, 2003). doi:10.1152/ajplung.00442.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/3/L514    most recent
00442.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ware, L. B.
Right arrow Articles by Matthay, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ware, L. B.
Right arrow Articles by Matthay, M. A.
Submitted on December 20, 2002
Accepted on May 11, 2003

Protein C and Thrombomodulin in Human Acute Lung Injury

Lorraine B. Ware1*, Xiaohui Fang2, and Michael A. Matthay3

1 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
2 Cardiovascular Research Institute, University of California, San Francisco, CA, USA
3 Cardiovascular Research Institute, University of California, San Francisco, CA, USA; Departments of Medicine and Anesthesia, University of California, San Francisco, CA, USA

* To whom correspondence should be addressed. E-mail: lorraine.ware{at}vanderbilt.edu.

Decreased circulating protein C and increased circulating thrombomodulin are markers of the prothrombotic, antifibrinolytic state associated with poor outcomes in sepsis, but have not been measured in patients with ALI/ARDS. We measured circulating and intra-alveolar protein C and thrombomodulin in 45 patients with ALI/ARDS from septic and non-septic causes and correlated the levels with clinical outcomes. Plasma protein C levels were lower in ALI/ARDS (37 ± 14%) compared to normals (n=10, 125 ± 24%, p < .001). Lower levels of protein C were associated with worse clinical outcomes including death, fewer ventilator-free days, and more non-pulmonary organ failures, even when only patients without sepsis (n = 25) were analyzed. Levels of thrombomodulin in pulmonary edema fluid from ALI/ARDS patients (704 ± 678 ng/ml) were over ten-fold higher than normal plasma (53 ± 28 ng/ml, p = .001) and two-fold higher than ALI/ARDS plasma (307 ± 244 ng/ml, p = .001). Higher edema fluid thrombomodulin levels were associated with worse clinical outcomes. The higher levels in edema fluid compared to plasma suggest local release of soluble thrombomodulin in the lung, possibly from a lung epithelial source. To determine whether lung epithelial cells can release thrombomodulin, A549 cells and primary isolates of human alveolar type II cells were exposed to H2O2 or inflammatory cytokines. Both epithelial cell types released thrombomodulin into the media. In summary, the protein C system is markedly disrupted in patients with ALI/ARDS from both septic and non-septic causes. The protein C system may be a potential therapeutic target in patients with ALI/ARDS.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. D. Liu, J. Levitt, H. Zhuo, R. H. Kallet, S. Brady, J. Steingrub, M. Tidswell, M. D. Siegel, G. Soto, M. W. Peterson, et al.
Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 618 - 623.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware
Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. D. Liu and M. A. Matthay
Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J. A Bastarache, L. Wang, T. Geiser, Z. Wang, K. H Albertine, M. A Matthay, and L. B Ware
The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor
Thorax, July 1, 2007; 62(7): 608 - 616.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood, April 15, 2007; 109(8): 3161 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. Wang, J. A. Bastarache, N. Wickersham, X. Fang, M. A. Matthay, and L. B. Ware
Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation
Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 497 - 503.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. S. Calfee and M. A. Matthay
Nonventilatory Treatments for Acute Lung Injury and ARDS
Chest, March 1, 2007; 131(3): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D. Christie, N. Robinson, L. B. Ware, M. Plotnick, J. De Andrade, V. Lama, A. Milstone, J. Orens, A. Weinacker, E. Demissie, et al.
Association of Protein C and Type 1 Plasminogen Activator Inhibitor with Primary Graft Dysfunction
Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware, E. Camerer, K. Welty-Wolf, M. J. Schultz, and M. A. Matthay
Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L307 - L311.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
M. Cepkova and M. A. Matthay
Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
J Intensive Care Med, May 1, 2006; 21(3): 119 - 143.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. R. Bernard
Acute Respiratory Distress Syndrome: A Historical Perspective
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 798 - 806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. van der Poll, M. Levi, J. A. Nick, and E. Abraham
Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1125 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Parsons, M. A. Matthay, L. B. Ware, M. D. Eisner, and and the National Heart, Lung, Blood Institute Acut
Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L426 - L431.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Bowler, B. Duda, E. D. Chan, J. J. Enghild, L. B. Ware, M. A. Matthay, and M. W. Duncan
Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1095 - L1104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. H. Hastings, H. G. Folkesson, and M. A. Matthay
Mechanisms of alveolar protein clearance in the intact lung
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L679 - L689.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.